Andra AP fonden Buys Shares of 20,200 Teleflex Incorporated (NYSE:TFX)

Andra AP fonden bought a new stake in Teleflex Incorporated (NYSE:TFX) during the second quarter, Holdings Channel.com reports. The institutional investor bought 20,200 shares of the medical technology company’s stock, valued at approximately $4,249,000.

A number of other large investors also recently bought and sold shares of TFX. International Assets Investment Management LLC lifted its position in Teleflex by 20,300.0% in the fourth quarter. International Assets Investment Management LLC now owns 2,244 shares of the medical technology company’s stock valued at $560,000 after buying an additional 2,233 shares during the last quarter. Victory Capital Management Inc. lifted its position in shares of Teleflex by 47.8% during the fourth quarter. Victory Capital Management Inc. now owns 21,865 shares of the medical technology company’s stock worth $5,452,000 after purchasing an additional 7,070 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of Teleflex by 35.5% during the fourth quarter. BNP Paribas Financial Markets now owns 39,735 shares of the medical technology company’s stock worth $9,908,000 after purchasing an additional 10,405 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Teleflex by 8.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 356,532 shares of the medical technology company’s stock worth $88,900,000 after purchasing an additional 27,048 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. lifted its position in shares of Teleflex by 5.6% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 1,489 shares of the medical technology company’s stock worth $371,000 after purchasing an additional 79 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on TFX shares. Truist Financial increased their price target on shares of Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research report on Monday, August 5th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Royal Bank of Canada increased their price target on shares of Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Finally, Stephens increased their price target on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $265.57.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the transaction, the director now directly owns 5,496 shares in the company, valued at $1,313,159.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.43% of the stock is currently owned by insiders.

Teleflex Stock Down 0.9 %

Shares of NYSE:TFX opened at $244.53 on Thursday. The firm’s 50 day moving average price is $231.65 and its 200 day moving average price is $219.57. The stock has a market cap of $11.52 billion, a price-to-earnings ratio of 39.25, a price-to-earnings-growth ratio of 2.22 and a beta of 1.15. Teleflex Incorporated has a fifty-two week low of $177.63 and a fifty-two week high of $257.85. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.36.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.09. The firm had revenue of $749.70 million for the quarter, compared to analysts’ expectations of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The firm’s revenue was up .9% compared to the same quarter last year. During the same quarter last year, the company earned $3.41 earnings per share. As a group, equities research analysts predict that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 16th. Shareholders of record on Thursday, August 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Thursday, August 15th. This represents a $1.36 annualized dividend and a yield of 0.56%. Teleflex’s dividend payout ratio is currently 21.83%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.